The new JV company will look to offer endoscopy solutions with an initial focus on “needs of emerging markets,” according to Tokyo-based Pentax.
“With Pentax Medical as our partner, this joint venture provides Aohua with the immediate opportunity to reach more patients throughout the world,” Aohua CEO Dr. Xiaozhou Gu said in a prepared statement.
“We have been committed to developing innovative technology, and our employees’ hard work and dedication will enable us to continue to deliver better and affordable endoscopy solutions that improve patient care. This collaboration brings together combined strengths of Pentax Medical’s global infrastructure and the capabilities and knowledge of the leading endoscope company in China. We look forward to the opportunity leveraging these synergies towards the improvement of patient health globally,” Hoya chief legal officer Augustine Yee said in a press release.
The new company will operate under the moniker Pentax-Aohua Medical Tech, and will be headquartered in Asia with plans to develop and commercialize products in emerging markets in Asia, Latin America, Eastern Europe, the Middle East and Africa.
“We are excited to establish this collaboration with Aohua that further advances our mission to improve the standard of patient care and quality of healthcare around the world. The complementary nature of Pentax Medical and Aohua’s capabilities will address key healthcare challenges and our two companies share a vision of delivering improved healthcare through early detection of cancer and other GI diseases in these growing markets,” Pentax Medical chief marketing officer David Woods said in prepared remarks.
“Instilling clinical confidence by delivering high performance, reliability and value to our customers is at the core of everything we do. Now Pentax Medical along with Aohua looks forward to offering endoscopy solutions in the emerging countries all over the world,” Pentax Medical global prez Gerald Bottero said in a prepared release.